Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Hautarzt ; 58(1): 54-5, 2007 Jan.
Article in German | MEDLINE | ID: mdl-16705462

ABSTRACT

A 6 year old girl presented with flat-topped, skin-colored, partly grouped papules with slightly roughened surface on the left side of the forehead and around the left orbit. In an off-label use imiquimod 5% cream was applied twice a week before bedtime and was rinsed off in the morning. After four weeks of treatment the lesions had vanished completely. We suggest imiquimod 5% cream as a treatment option for juvenile plane warts even in children and in the face.


Subject(s)
Aminoquinolines/administration & dosage , Facial Dermatoses/drug therapy , Facial Dermatoses/pathology , Warts/drug therapy , Warts/pathology , Adjuvants, Immunologic/administration & dosage , Administration, Topical , Child , Dermatologic Agents/administration & dosage , Female , Humans , Imiquimod , Treatment Outcome
2.
Allergy ; 59(12): 1318-25, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15507101

ABSTRACT

BACKGROUND: The atopy patch test (APT) was proposed to evaluate IgE-mediated sensitizations in patients with atopic eczema (AE). OBJECTIVE: The prevalence and agreement with clinical history and specific IgE (sIgE) of positive APT reactions was investigated in six European countries using a standardized method. METHODS: A total of 314 patients with AE in remission were tested in 12 study centers on clinically uninvolved, non-abraded back skin with 200 index of reactivity (IR)/g of house dust mite Dermatophagoides pteronyssinus, cat dander, grass, and birch pollen allergen extracts with defined major allergen contents in petrolatum. Extracts of egg white, celery and wheat flour with defined protein content were also patch tested. APT values were evaluated at 24, 48, and 72 h according to the European Task Force on Atopic Dermatitis (ETFAD) guidelines. In addition, skin-prick test (SPT) and sIgE and a detailed history on allergen-induced eczema flares were obtained. RESULTS: Previous eczema flares, after contact with specific allergens, were reported in 1% (celery) to 34% (D. pteronyssinus) of patients. The frequency of clear-cut positive APT reactions ranged from 39% with D. pteronyssinus to 9% with celery. All ETFAD intensities occured after 48 and 72 h. Positive SPT (16-57%) and elevated sIgE (19-59%) results were more frequent. Clear-cut positive APT with all SPT and sIgE testing negative was seen in 7% of the patients, whereas a positive APT without SPT or sIgE for the respective allergen was seen in 17% of the patients. APT, SPT and sIgE results showed significant agreement with history for grass pollen and egg white (two-sided Pr > /Z/ < or = 0.01). In addition, SPT and sIgE showed significant agreement with history for the other aeroallergens. With regard to clinical history, the APT had a higher specificity (64-91% depending on the allergen) than SPT (50-85%) or sIgE (52-85%). Positive APT were associated with longer duration of eczema flares and showed regional differences. In 10 non-atopic controls, no positive APT reaction was seen. CONCLUSION: Aeroallergens and food allergens are able to elicit eczematous skin reactions after epicutaneous application. As no gold standard for aeroallergen provocation in AE exists, the relevance of aeroallergens for AE flares may be evaluated by APT in addition to SPT and sIgE. The data may contribute to the international standardization of the APT.


Subject(s)
Allergens , Dermatitis, Atopic/diagnosis , Patch Tests , Adolescent , Adult , Aged , Aged, 80 and over , Allergens/immunology , Animals , Apium/immunology , Cats , Child , Child, Preschool , Dermatophagoides pteronyssinus/immunology , Europe , Female , Humans , Infant , Male , Middle Aged , Sensitivity and Specificity
3.
Hautarzt ; 55(7): 677-87; quiz 688, 2004 Jul.
Article in German | MEDLINE | ID: mdl-15197462

ABSTRACT

Eyelid eczemas are clinically and therapeutically clearly delineated, but remain a pathogenetically heterogeneous entity. The anatomic and functional conditions in the periorbital region make treatment difficult. Thus, in addition to frequent resistance to therapy and a tendency to recur, they pose a considerable diagnostic and therapeutic challenge to dermatologists and ophthalmologists. Even a comparatively small area of eyelid eczema can cause substantial suffering because of the burdensome symptoms and high aesthetic significance of this body region. This interdisciplinary overview deals in particular with current pathogenetic and therapeutic aspects of eyelid eczemas.


Subject(s)
Eczema/diagnosis , Eyelid Diseases/diagnosis , Patient Care Team , Diagnosis, Differential , Eczema/etiology , Eczema/therapy , Eyelid Diseases/etiology , Eyelid Diseases/therapy , Humans , Recurrence , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...